an expert’s thoughts on the fda approval of durvalumab in locally advanced lung cancers
Published 6 years ago • 357 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
3:07
the use of durvalumab in locally advanced nsclc
-
0:57
dr. patel on the fda approval of durvalumab in nsclc
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
3:31
fda d.i.s.c.o. burst edition: fda approval of imfinzi (durvalumab) for adult patients with locall...
-
0:46
fda approves capmatinib for advanced lung cancer
-
5:13
effectively managing treatment with durvalumab
-
1:49
fda approval of durvalumab for bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
1:06
the mechanism of action of durvalumab in the treatment of urothelial bladder cancer
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer